Portugal Trims Antibiotic Use by 5.2 Percent Since 2019, but Carbapenem-Resistant Klebsiella Infections More Than Double
Portugal used 5.2 percent fewer antibiotics in 2025 than in 2019, Infarmed and the DGS said on European Antibiotic Awareness Day, but bloodstream infections from carbapenem-resistant Klebsiella rose 107 percent. What parents should know.
Portugal used 5.2 percent fewer antibiotics in 2025 than in 2019, but infections caused by some of the hardest bacteria to treat have more than doubled over the same period. The figures were released today, European Antibiotic Awareness Day, by the medicines authority Infarmed, the Directorate-General of Health (DGS) and the national health institute INSA in a joint statement reported by Lusa via Notícias ao Minuto.
Total consumption fell from 19.3 to 18.3 defined daily doses per 1,000 inhabitants per day (a standard measure of how much of a medicine a population takes). Portugal's national target is 17.6 by 2030, a 9 percent cut. Infarmed told Lusa that the 2025 fall came after four years of increases and was driven by lower use in the community, while hospital use held steady. Preliminary data for the first half of 2026 suggest the decline is continuing.
Where resistance is getting worse
The picture on resistance is mixed. According to the joint statement, bloodstream infections caused by MRSA (a Staphylococcus aureus resistant to common antibiotics) fell 31.3 percent between 2019 and 2025, from 11.39 to 7.83 cases per 100,000 inhabitants. But bloodstream infections from Escherichia coli resistant to third-generation cephalosporins rose 31.9 percent, and those from Klebsiella pneumoniae resistant to carbapenems (a class of antibiotics kept for severe infections) rose 107 percent, from 2.93 to 6.06 cases per 100,000.
Portugal is not alone. The European Centre for Disease Prevention and Control (ECDC) said in its press release today that carbapenem-resistant K. pneumoniae bloodstream infections are up 72 percent across the EU and EEA since 2019, against a target of a 5 percent cut, and that EU antibiotic use in 2025 was only 5 percent below 2019, against a 20 percent reduction target for 2030. ECDC estimates on its awareness campaign page that more than 35,000 people die each year from antibiotic-resistant infections in the EU, Iceland and Norway.
One EU target where Portugal lags: first-choice antibiotics recommended for common infections made up 61.9 percent of consumption, below the European goal of at least 65 percent. Infarmed noted that the most dispensed antibiotic in pharmacies in 2025 was amoxicillin with clavulanic acid, a broad-spectrum combination, and said plain amoxicillin should be preferred where clinically appropriate.
What it means for you
This year's ECDC campaign is aimed at parents, under the theme "Care for your kids: use antibiotics wisely". The DGS, in a statement to Lusa, made the same point for Portugal: most respiratory infections in young children, especially after starting nursery, are caused by viruses, and antibiotics do not work against them.
- Prescription only. In Portugal, systemic antibiotics (antibióticos de ação sistémica, those that act throughout the body) require a doctor's prescription.
- Fever or cough is not a reason on its own. The DGS says fever, cough or a sore throat do not by themselves mean a child needs an antibiotic. ECDC adds that colds and flu are viral.
- No leftovers. The DGS advises against using antibiotics left over from an earlier course or prescribed to someone else.
- Follow the dose and duration your health professional sets.
The DGS also wants parents to know how infections usually progress, so they can tell when a child needs to be seen again. The rise in respiratory infections this autumn was covered in our October report on health centre visits, and new limits on antibiotics for animals in our story on veterinary prescriptions.